Published in Semin Arthritis Rheum on December 01, 2002
Ileal pouchitis and arthritis. Semin Arthritis Rheum (2003) 0.90
Arthritis accompanying ileal pouchitis or undifferentiated HLA B27-related spondyloarthropathy? Rheumatol Int (2005) 0.75
Arthritis related to ileal pouchitis following total proctocolectomy for ulcerative colitis. Semin Arthritis Rheum (2001) 2.33
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis (2009) 3.66
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum (2005) 3.31
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol (2005) 2.90
Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease. Gastroenterology (2011) 2.21
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol (2012) 2.18
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol (2010) 1.81
Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol (2007) 1.77
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis (2013) 1.74
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis (2012) 1.71
Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. Rheumatology (Oxford) (2009) 1.60
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol (2011) 1.52
Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol (2003) 1.51
Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? Arthritis Care Res (Hoboken) (2012) 1.46
The HLA-B*2709 subtype confers susceptibility to spondylarthropathy. Arthritis Rheum (2002) 1.43
An unusual cause of dysphagia. J Rheumatol (2012) 1.38
European evidence-based Consensus on the management of ulcerative colitis: Special situations. J Crohns Colitis (2008) 1.34
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature. Arthritis Rheum (2008) 1.30
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res (Hoboken) (2013) 1.29
Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. Gastroenterology (2007) 1.24
Enthesitis. Best Pract Res Clin Rheumatol (2006) 1.21
Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol (2006) 1.19
The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study. Clin Rheumatol (2011) 1.15
Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis. Inflamm Bowel Dis (2010) 1.11
Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study. Am J Gastroenterol (2005) 1.11
Pharmacological management of SAPHO syndrome. Expert Opin Investig Drugs (2006) 1.08
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum (2007) 1.07
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. Inflamm Bowel Dis (2005) 1.06
Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis (2009) 1.06
Dactylolysis spontanea or ainhum involving the big toe. J Rheumatol (2005) 1.05
The HLA-B*2709 subtype in a woman with early ankylosing spondylitis. Arthritis Rheum (2007) 1.04
Attachment and quality of life in patients with inflammatory bowel disease. Int J Colorectal Dis (2014) 1.04
Hepatitis C virus and arthritis. Rheum Dis Clin North Am (2003) 1.04
Diffuse idiopathic skeletal hyperostosis: differentiation from ankylosing spondylitis. Curr Rheumatol Rep (2009) 1.03
International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum (2009) 1.02
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis (2010) 1.02
Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J Gastroenterol (2006) 1.02
Hepatitis C virus-related arthritis. Autoimmun Rev (2008) 1.02
New approaches in the treatment of Adamantiades-Behçet's disease. Curr Opin Rheumatol (2006) 1.01
European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis (2015) 1.01
Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases. Rheumatol Int (2007) 1.01
Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum (2004) 0.98
Adalimumab in active ulcerative colitis: a "real-life" observational study. Dig Liver Dis (2013) 0.98
Efficacy of infliximab in resistant psoriatic arthritis. Arthritis Rheum (2003) 0.96
Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J Rheumatol (2009) 0.96
Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study. Arthritis Rheum (2006) 0.95
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. Rheumatology (Oxford) (2013) 0.94
Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab. Clin Exp Rheumatol (2011) 0.94
Parental bonding and inflammatory bowel disease. Psychosomatics (2010) 0.93
Fast spin echo-T2-weighted sequences with fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the flexor digitorum tendons. Arthritis Rheum (2002) 0.93
Adult attachment and early parental experiences in patients with Crohn's disease. Psychosomatics (2010) 0.93
Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue. World J Gastroenterol (2006) 0.93
Aortitis and periaortitis in ankylosing spondylitis. Joint Bone Spine (2010) 0.92
Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's disease. Inflamm Bowel Dis (2007) 0.91
Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. J Rheumatol (2002) 0.91
Probiotic therapy to prevent pouchitis onset. Dis Colon Rectum (2005) 0.90
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology. Clin Exp Rheumatol (2011) 0.90
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum (2004) 0.89
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review. J Rheumatol (2008) 0.87
The challenge of early diagnosis of psoriatic arthritis. J Rheumatol (2008) 0.87
Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study. J Rheumatol (2003) 0.87
Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid. Rheumatology (Oxford) (2009) 0.87
Developing new classification criteria for diffuse idiopathic skeletal hyperostosis: back to square one. Rheumatology (Oxford) (2012) 0.87
Ultrasound and magnetic resonance imaging in the evaluation of psoriatic dactylitis: status and perspectives. J Rheumatol (2013) 0.86
Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study. Medicine (Baltimore) (2016) 0.86
Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis. J Rheumatol (2009) 0.86
Vascular endothelial growth factor gene polymorphisms in Behçet's disease. J Rheumatol (2004) 0.86
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study. Rheumatology (Oxford) (2010) 0.85
Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab. Clin Exp Rheumatol (2011) 0.85
Management of reactive arthritis. Expert Opin Pharmacother (2004) 0.84
Colour duplex ultrasonography in the management of giant cell arteritis. Clin Rheumatol (2003) 0.83
Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease. J Clin Microbiol (2009) 0.83
Autoantibodies in patients with chronic hepatitis C virus infection: pitfalls for the diagnosis of rheumatic diseases. Autoimmun Rev (2011) 0.83
Management issues with elderly-onset rheumatoid arthritis: an update. Drugs Aging (2005) 0.83
Role of trauma in psoriatic arthritis. J Rheumatol (2008) 0.82
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. Intern Emerg Med (2011) 0.82
Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis. Clin Exp Rheumatol (2012) 0.82
Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study. Clin Exp Rheumatol (2014) 0.82
The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept. Clin Exp Rheumatol (2011) 0.81
Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy. Dermatology (2007) 0.81
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls. J Behav Med (2012) 0.81
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing. Inflamm Bowel Dis (2010) 0.81
Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis. Ann Rheum Dis (2009) 0.81
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis. World J Gastroenterol (2013) 0.81
Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis. Int J Antimicrob Agents (2008) 0.80
Clinical course of microscopic colitis in a single-center cohort study. J Crohns Colitis (2011) 0.80
Low frequency of axial involvement in southern Italian Caucasian children with HLA-B27 positive juvenile onset undifferentiated spondyloarthritis. Clin Exp Rheumatol (2012) 0.80